CN114539078B - Active small molecular probe for specifically sorting monoamine oxidase, preparation method and application thereof - Google Patents
Active small molecular probe for specifically sorting monoamine oxidase, preparation method and application thereof Download PDFInfo
- Publication number
- CN114539078B CN114539078B CN202210161073.3A CN202210161073A CN114539078B CN 114539078 B CN114539078 B CN 114539078B CN 202210161073 A CN202210161073 A CN 202210161073A CN 114539078 B CN114539078 B CN 114539078B
- Authority
- CN
- China
- Prior art keywords
- drying
- reaction
- probe
- specific probe
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000010909 Monoamine Oxidase Human genes 0.000 title claims abstract description 72
- 108010062431 Monoamine oxidase Proteins 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000003068 molecular probe Substances 0.000 title claims abstract description 5
- 239000000523 sample Substances 0.000 claims abstract description 74
- 238000006243 chemical reaction Methods 0.000 claims abstract description 40
- 238000000338 in vitro Methods 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 21
- HTJMXYRLEDBSLT-UHFFFAOYSA-N 1,2,4,5-tetrazine Chemical group C1=NN=CN=N1 HTJMXYRLEDBSLT-UHFFFAOYSA-N 0.000 claims abstract description 18
- 230000000694 effects Effects 0.000 claims abstract description 10
- URYYVOIYTNXXBN-OWOJBTEDSA-N trans-cyclooctene Chemical group C1CCC\C=C\CC1 URYYVOIYTNXXBN-OWOJBTEDSA-N 0.000 claims abstract description 6
- 230000008859 change Effects 0.000 claims abstract description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 48
- 238000001035 drying Methods 0.000 claims description 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 18
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 18
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 18
- 238000003818 flash chromatography Methods 0.000 claims description 16
- -1 (E) -cycloocta-4-en-1-yl (2-bromoethyl) Chemical group 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 10
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- TZCWQOLNDQPNKD-UHFFFAOYSA-N 4-[[methyl(prop-2-ynyl)amino]methyl]phenol Chemical compound C#CCN(C)CC1=CC=C(O)C=C1 TZCWQOLNDQPNKD-UHFFFAOYSA-N 0.000 claims description 6
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- 239000012074 organic phase Substances 0.000 claims description 6
- QEXGWGCXTFIWCH-UHFFFAOYSA-N CC(C)(C)[Si](C)(C)OC(C=CC(C)=C1)=C1Cl Chemical compound CC(C)(C)[Si](C)(C)OC(C=CC(C)=C1)=C1Cl QEXGWGCXTFIWCH-UHFFFAOYSA-N 0.000 claims description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 5
- 238000010791 quenching Methods 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 5
- 150000003384 small molecules Chemical class 0.000 claims description 5
- PKZBRYXOYZUZIR-DUXPYHPUSA-N (3E)-cyclooct-3-en-1-ol Chemical compound OC1CCCC\C=C\C1 PKZBRYXOYZUZIR-DUXPYHPUSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- FJMMADPCDJNXAH-UHFFFAOYSA-N cyclooct-4-en-1-yl (4-nitrophenyl) carbonate Chemical compound O=C(OC1=CC=C(C=C1)N(=O)=O)OC1CCC=CCCC1 FJMMADPCDJNXAH-UHFFFAOYSA-N 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 claims description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 claims description 3
- RXHVIRQFFNONIK-UHFFFAOYSA-N CN(CC(C=C1)=CC(Cl)=C1O)CC#C Chemical compound CN(CC(C=C1)=CC(Cl)=C1O)CC#C RXHVIRQFFNONIK-UHFFFAOYSA-N 0.000 claims description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- UHCSTIWYLVWCMK-UHFFFAOYSA-N [4-(bromomethyl)-2-chlorophenoxy]-tert-butyl-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)OC1=CC=C(CBr)C=C1Cl UHCSTIWYLVWCMK-UHFFFAOYSA-N 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- XHFGWHUWQXTGAT-UHFFFAOYSA-N n-methylpropan-2-amine Chemical compound CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 claims description 3
- 230000000171 quenching effect Effects 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- SKDHHIUENRGTHK-UHFFFAOYSA-N 4-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=C(C(Cl)=O)C=C1 SKDHHIUENRGTHK-UHFFFAOYSA-N 0.000 claims description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 239000012044 organic layer Substances 0.000 claims description 2
- 239000012460 protein solution Substances 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 239000012312 sodium hydride Substances 0.000 claims description 2
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 2
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims 4
- 239000007795 chemical reaction product Substances 0.000 claims 3
- UBHZUDXTHNMNLD-UHFFFAOYSA-N dimethylsilane Chemical compound C[SiH2]C UBHZUDXTHNMNLD-UHFFFAOYSA-N 0.000 claims 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 238000011156 evaluation Methods 0.000 claims 1
- 239000012264 purified product Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 17
- 102000004169 proteins and genes Human genes 0.000 abstract description 16
- 238000003786 synthesis reaction Methods 0.000 abstract description 15
- 238000001514 detection method Methods 0.000 abstract description 14
- 239000002994 raw material Substances 0.000 abstract description 3
- 238000001228 spectrum Methods 0.000 description 32
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 18
- 229910052799 carbon Inorganic materials 0.000 description 18
- 229910052739 hydrogen Inorganic materials 0.000 description 18
- 239000001257 hydrogen Substances 0.000 description 18
- 238000001819 mass spectrum Methods 0.000 description 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 16
- 230000008569 process Effects 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 9
- 238000010183 spectrum analysis Methods 0.000 description 9
- 238000000746 purification Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 5
- 239000000872 buffer Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 208000015122 neurodegenerative disease Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- OVFJHQBWUUTRFT-UHFFFAOYSA-N 1,2,3,4-tetrahydrotetrazine Chemical group C1=CNNNN1 OVFJHQBWUUTRFT-UHFFFAOYSA-N 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003032 molecular docking Methods 0.000 description 2
- 230000004770 neurodegeneration Effects 0.000 description 2
- 238000006395 oxidase reaction Methods 0.000 description 2
- JKANAVGODYYCQF-UHFFFAOYSA-N prop-2-yn-1-amine Chemical group NCC#C JKANAVGODYYCQF-UHFFFAOYSA-N 0.000 description 2
- 238000002331 protein detection Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- LOVPHSMOAVXQIH-UHFFFAOYSA-M (4-nitrophenyl) carbonate Chemical compound [O-]C(=O)OC1=CC=C([N+]([O-])=O)C=C1 LOVPHSMOAVXQIH-UHFFFAOYSA-M 0.000 description 1
- JDTFHOGNNYGIBU-UHFFFAOYSA-N 2-bromoethyl carbamate Chemical compound NC(=O)OCCBr JDTFHOGNNYGIBU-UHFFFAOYSA-N 0.000 description 1
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical class OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003271 compound fluorescence assay Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/48—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
- G01N2333/90605—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4)
- G01N2333/90633—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) in general
- G01N2333/90638—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) in general with a definite EC number (1.4.3.-)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
The invention discloses an active small molecular probe for specifically sorting monoamine oxidase, a preparation method and application thereof. The structural formula of the in vitro specific probe is shown as followsWhen R is 1 Is composed ofWhen the in vitro specific probe has a structural formulaThe in vitro specific probe is specifically combined with MAO-A and is marked as C-TCO; r 1 Is composed ofWhen the in vitro specific probe has a structural formulaThe in vitro specific probe binds specifically to MAO-B, denoted PA-TCO. The trans-cyclooctene structure of the specific probe generates a bioorthogonal reaction with a dye with a 1,2,4, 5-tetrazine derivative structure, a product can generate strong fluorescence, and the activity of monoamine oxidase A/B in different biological systems is determined by fluorescence change. The probe is prepared by a full-chemical synthesis method, the raw materials are cheap and easy to obtain, the preparation process is simple and easy to synthesize, the protein can be specifically identified, the detection speed is high, and the probe is used for in-vitro semi-quantitative typing detection of monoamine oxidase.
Description
Technical Field
The invention belongs to the field of organic/biochemical technology, and particularly relates to an active small molecular probe for specifically sorting monoamine oxidase, and a preparation method and application thereof.
Background
Proteins are essential substances for all organisms and can be used as important biomarkers for health conditions and disease states, and rapid detection of proteins is critical for diagnosis and treatment of diseases. The method commonly used today for detecting protein level expression is western blotting, which is a protein detection technique for detecting a specific antigen with a specific antibody, and is now widely used in many fields such as gene expression research at protein level, antibody activity detection, and early diagnosis of diseases. The detection method has many disadvantages, such as long incubation time of the antibody, high antibody cost and complicated operation process. The existing other methods for detecting protein comprise immunofluorescence, liquid chromatography, mass spectrometry, enzyme-linked immunosorbent assay and the like, and the methods still cannot get rid of antibodies, require expensive instruments and professional technicians, and are difficult to realize quantitative detection and the like. Therefore, there is a need to develop a low-cost, high-throughput, high-specificity, low-usage, or even antibody-free protein detection method for analyzing proteins in complex samples.
Monoamine oxidase (MAOs) is A protein expressed on the outer mitochondrial membrane, and MAOs are classified into two subtypes, MAO-A and MAO-B, according to their binding specificity to natural substrates or probes, and abnormally expressed MAO-A or MAO-B causes neurodegenerative diseases and disorders, such as the overexpression of MAO-A in humans, which is strongly linked to schizophreniA and depression, and MAO-B is abundantly expressed in the brains of patients with parkinson's disease and alzheimer's disease. However, MAO-A and MAO-B are highly homologous, with A degree of gene similarity of up to 90% and A degree of active amino acid sequence similarity of up to 70%, which are difficult to distinguish. Therefore, there is a need to develop a specific differentiation method to realize typing and early prognosis of neurodegenerative diseases at the genetic level.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide an active small molecule probe for specifically detecting monoamine oxidase, and a preparation method and application thereof. The probe subversively replaces the incubation and application of the antibody in the traditional detection by a preparation method of full chemical synthesis, the raw materials are easy to obtain, the preparation process is simple, the subsequent detection process does not need fussy operation, and the monoamine oxidase can be specifically identified.
In order to solve the problems of the prior art, the invention adopts the technical scheme that:
the structural formula of the small molecular probe for specifically sorting the activity of monoamine oxidase is shown as followsWherein R is 1 Is composed of
As an improvement, when R1 isWhen the in vitro specific probe is used, the structural formula is shown as follows,the in vitro specific probe is specifically combined with MAO-A and is marked as C-TCO; r1 isWhen the in vitro specific probe has the structural formula of->The in vitro specific probe binds specifically to MAO-B, denoted PA-TCO.
The preparation method of the in vitro specific probe is that when R1 isWhen the in vitro specific probe has the structural formula of->The preparation method is specifically marked as CL-TCO and comprises the following steps:
the first step is as follows: the reaction time required in the synthesis process of the 2-chloro-4- ((methyl (prop-2-yn-1-yl) amino) methyl) phenol is 4-10h; the second step is that: heating reflux time of the synthetic process of the tert-butyl (2-chloro-4-methylphenoxy) dimethylsilane is 2-8h; the third step: the reaction time of the synthesis process of the (4- (bromomethyl) -2-chlorophenoxy) (tert-butyl) dimethylsilane is 5-10h; the fourth step: (E) -the reaction time of the synthesis process of tert-butyl (2-chloro-4- ((cyclooct-4-en-1-yloxy) methyl) phenoxy) dimethylsilane is 2-10h; the fifth step: (E) -synthesis of N- (3- (2-chloro-4- ((cyclooct-4-en-1-oxy) methyl) phenoxy) propyl) -N-methylpropan-2-yn-1-amine (E) -2-chloro-4- ((cyclooct-4-en-1-propoxy) methyl) phenol, 1, 3-dibromopropane are dissolved in acetonitrile, potassium carbonate is added, reflux is carried out for 2-4h under nitrogen protection, N-methylpropan-2-amine is added after cooling to room temperature, and the potassium carbonate is stirred for 22-48h at 40 ± 10 ℃;
when R2 isWhen the in vitro specific probe has a structural formulaThe specific preparation method is marked as PA-TCO and comprises the following steps:
the first step is as follows: (E) The reaction process of the-cycloocta-4-ene-1-yl (4-nitrophenyl) carbonate is carried out for 10-20h at room temperature; the second step is that: (E) The reaction process of the-cycloocta-4-en-1-yl (2-bromoethyl) carbamate is carried out for 14 to 22 hours at room temperature; the third step: stirring 4- ((methyl (prop-2-yne-1-yl) amino) methyl) phenol at room temperature for 30-90min during the reaction process, and adding sodium acetate to react for 4-10h; the fourth step: (E) During the reaction of-cyclooct-4-en-1-yl (2- (4- ((methyl (prop-2-yn-1-yl) amino) methyl) phenoxy) ethyl) carbamate, 4- ((methyl (prop-2-yn-1-yl) amino) methyl) phenol, (E) -cyclooct-4-en-1-yl (2-bromoethyl) carbamate and potassium carbonate are dissolved in acetonitrile solution, and heated under nitrogen for reflux for 10-20h.
200 μ L of a monoamine oxidase reaction system including PBS buffer with pH =6-8, monoamine oxidase A/B (20-80 μ g/mL), CL-TCO/PA-TCO (20-50 μ M) was prepared in advance, and pre-incubated at 37 ℃ for 0.5-2h with shaking. The procedure for separating the probe-protein conjugate with the separation column was as follows: remove the bottom seal of the column and release the lid (without removing the lid). The column was placed in a 1.5-2.0mL collection tube and centrifuged for 1-30min to remove the stock solution.
Sample loading: the column was placed in A new 0.5-5.0m centrifuge tube, and 30-130. Mu. of MAO-A/MAO-B solution and C-TCO/PA-TCO solution were slowly added dropwise to the center of the column packed resin bed, centrifuged for 2-30min, and MAO-A/B sample recognized by the specific probe was collected.
The application of the in vitro specific probe in vitro typing detection of monoamine oxidase A/B is characterized in that a trans-cyclooctene structure of the specific probe can perform bio-orthogonal reaction with a dye with a 1,2,4, 5-tetrazine structure, the specific probe does not have fluorescence, the fluorescence of a dye molecule with the 1,2,4, 5-tetrazine structure is weak, the product can generate stronger fluorescence, and the activity of monoamine oxidase A/B in different biological systems can be determined through fluorescence change. And (2) reacting the specifically bound protein-probe solution with a dye solution with a 1,2,4, 5-tetrazine structure in equal volume, wherein the concentration of the protein solution modified by the specific probe is 5-50 times of that of the dye solution with the 1,2,4, 5-tetrazine structure, the reaction time is 5-30min, the reaction temperature is 20-37 ℃, after the reaction, a fluorescence scanning detection (Ex =430 nm) is carried out, and the fluorescence value is increased, so that the probe is proved to successfully and specifically recognize the monoamine oxidase.
Has the advantages that:
compared with the prior art, the in vitro specific probe and the preparation method and the application thereof have the following advantages:
1. high specificity: the synthesized specific probe can be covalently combined with a target protein to specifically recognize the protein;
2. the method is cheap and fast: the specific probe C-TCO/PA-TCO of the MAO-A/MAO-B can be obtained by chemical synthesis, the synthesis raw materials are cheap and easy to obtain, and the synthesis process is simple and easy to implement;
3. the detection step does not need complex antibody incubation and cleaning processes, and the detection process is rapid.
Drawings
FIG. 1 shows the molecular structure of the specific probe C-TCO for MAO-A;
FIG. 2 shows the molecular structure of specific probe PA-TCO for MAO-B;
FIG. 3 (A) is A scheme for the synthesis of the specific probe C-TCO for MAO-A;
FIG. 3 (B) is nuclear magnetic hydrogen spectrum, carbon spectrum and high resolution mass spectrum of compound B2;
FIG. 3 (c) is a nuclear magnetic hydrogen spectrum, a carbon spectrum and a high-resolution mass spectrum of the compound B3;
FIG. 3 (d) is a nuclear magnetic hydrogen spectrum, a carbon spectrum and a high-resolution mass spectrum of the compound B5;
FIG. 3 (e) is a nuclear magnetic hydrogen spectrum, a carbon spectrum and a high-resolution mass spectrum of the compound B6;
FIG. 3 (f) is nuclear magnetic hydrogen, carbon and high resolution mass spectra of compound CL-TCO;
FIG. 4 (a) is a synthesis route of specific probe PA-TCO for MAO-B;
FIG. 4 (b) is nuclear magnetic hydrogen spectrum, carbon spectrum and high resolution mass spectrum of compound C3;
FIG. 4 (C) is a nuclear magnetic hydrogen spectrum, a carbon spectrum and a high resolution mass spectrum of compound C4;
FIG. 4 (d) is a nuclear magnetic hydrogen spectrum, a carbon spectrum and a high resolution mass spectrum of compound C6;
FIG. 4 (e) is nuclear magnetic hydrogen, carbon and high resolution mass spectra of compound PA-TCO;
FIG. 5 is a schematic diagram of a mechanism for simulating specific probe recognition by molecular docking;
FIG. 6 is A fluorescence spectrum of the bioorthogonal reaction of MAO-A-C-TCO with 1,2,4, 5-tetrazine structural dye;
FIG. 7 is a fluorescence spectrum of the bio-orthogonal reaction of MAO-B-PA-TCO with 1,2,4, 5-tetrazine structural dye.
Detailed Description
Example 1 chemical Synthesis of the specific Probe C-TCO MAO-A
The CL-TCO structure is shown in figure 1, and the synthesis process is shown in figure 3 (a).
The first step is as follows: dissolving 2-chloro-4- ((methyl (prop-2-yne-1-yl) amino) methyl) phenol (1 eq.) and tert-butyldimethylchlorosilane (1.5 eq.) in dichloromethane, adding dropwise triethanolamine under the protection of ice bath and nitrogen, reacting for 6h, adding water after the reaction is finished, and extracting with dichloromethane. The organic phase is washed with 1M dilute hydrochloric acid. Adding anhydrous sodium sulfate and drying. Purification by flash column chromatography followed by spin drying gave tert-butyl (2-chloro-4-methylphenoxy) dimethylsilane. The spectrum analysis is shown in FIG. 3 (b), wherein i) is NMR hydrogen spectrum, (ii) is NMR carbon spectrum, and (iii) is high resolution mass spectrum.
The second step is that: dissolving tert-butyl (2-chloro-4-methylphenoxy) dimethylsilane (1 eq.) in carbon tetrachloride, adding N-bromosuccinimide (1 eq.) under the condition of ice bath, and heating and refluxing for 3h. Adding water for extraction. Drying over anhydrous sodium sulfate gave (4- (bromomethyl) -2-chlorophenoxy) (tert-butyl) dimethylsilane. The spectrum analysis is shown in FIG. 3 (c), (i) is NMR hydrogen spectrum, (ii) is NMR carbon spectrum, and (iii) is high resolution mass spectrum.
The third step: trans-cyclooctenol (1.5 eq.) was dissolved in N, N-dimethylformamide, sodium hydride (2 eq.) was slowly added under ice bath conditions, stirred at room temperature for 30min, then 4-hydroxy trans-cyclooctene (1 eq.) was added, and reacted for 5h. After the reaction, water was added to quench the reaction, followed by extraction with dichloromethane. Dried over anhydrous sodium sulfate. Purification by flash column chromatography and spin-drying gave (E) -tert-butyl (2-chloro-4- ((cyclooct-4-en-1-yloxy) methyl) phenoxy) dimethylsilane. The spectrum analysis is shown in FIG. 3 (d), (i) is NMR hydrogen spectrum, (ii) is NMR carbon spectrum, and (iii) is high resolution mass spectrum.
The fourth step: (E) -tert-butyl (2-chloro-4- ((cyclooct-4-en-1-yloxy) methyl) phenoxy) dimethylsilane (1 eq.) was dissolved in tetrahydrofuran and tetrabutylammonium fluoride (1.2 eq.) was added dropwise under ice-bath conditions. Stir at rt for 2h. After the reaction is finished, water is added for quenching. Extraction was carried out with dichloromethane. Dried over anhydrous sodium sulfate. Purification by flash column chromatography and spin-drying gave (E) -2-chloro-4- ((cyclooct-4-en-1-propoxy) methyl) phenol. The spectrum analysis is shown in FIG. 3 (e), (i) is NMR hydrogen spectrum, (ii) is NMR carbon spectrum, and (iii) is high-resolution mass spectrum.
The fifth step: (E) -2-chloro-4- ((cyclooct-4-en-1-propoxy) methyl) phenol (1 eq.) and 1, 3-dibromopropane (2 eq.) were dissolved in acetonitrile, and potassium carbonate (1 eq.) was added and refluxed under nitrogen for 3h. After cooling to room temperature, N-methylpropan-2-amine (3 eq.) and potassium carbonate (3 eq.) were added and stirred at 40 ℃ for 24h. The solvent was spin dried and extracted with water and ethyl acetate. Dried over anhydrous sodium sulfate. Purification by flash column chromatography, spin-drying to give the final compound CL-TCO. The spectrum analysis is shown in FIG. 3 (f), (i) is NMR hydrogen spectrum, (ii) is NMR carbon spectrum, and (iii) is high resolution mass spectrum.
Example 2 chemical Synthesis of PA-TCO as specific Probe MAO-B
The PA-TCO structure is shown in FIG. 2, and the synthesis process is shown in FIG. 4 (a).
The first step is as follows: 4-Hydroxytrans-cyclooctene and pyridine (1.2 eq.) were dissolved in dichloromethane in an ice bath and 4-nitrophenylcarbonyl chloride (1.2 eq.) was slowly added dropwise and stirred at room temperature for 12h. After the reaction was completed, water and methylene chloride were added for extraction, and the organic phase was washed with 1M aqueous sodium carbonate solution, dried over anhydrous sodium sulfate, purified by flash column chromatography, and spin-dried to obtain (E) -cyclooct-4-en-1-yl (4-nitrophenyl) carbonate. The spectrum analysis is shown in FIG. 4 (b), (i) is NMR hydrogen spectrum, (ii) is NMR carbon spectrum, and (iii) is high-resolution mass spectrum.
The second step is that: 2-bromoethyl-1-amine (6 eq.) was dissolved in dichloromethane and (E) -cyclooct-4-en-1-yl (4-nitrophenyl) carbonate (1 eq.) was slowly added dropwise under nitrogen protection and stirred at room temperature for 16h. After the reaction is completed, extraction is added. The organic phase was washed with aqueous sodium bicarbonate solution, dried over anhydrous sodium sulfate, purified by flash column chromatography, and spin-dried to give (E) -cyclooct-4-en-1-yl (2-bromoethyl) carbamate. The spectrum analysis is shown in FIG. 4 (c), (i) is NMR hydrogen spectrum, (ii) is NMR carbon spectrum, and (iii) is high-resolution mass spectrum.
The third step: 4-hydroxybenzaldehyde (1 eq.) is dissolved in tetrahydrofuran, 4-hydroxybenzaldehyde-1 (1.2 eq.) is added to the reaction mixture under nitrogen protection, the mixture is stirred at room temperature for 30min, and then sodium acetate (1.4 eq.) is added to the mixture for reaction for 5h. The reaction mixture was quenched with saturated sodium bicarbonate. Extract with ethyl acetate (4 × 20 mL). The organic layers were combined, washed with saturated brine and dried over anhydrous sodium sulfate. Purification by flash column chromatography, spin-dried to give 4- ((methyl (prop-2-yn-1-yl) amino) methyl) phenol. The spectrum analysis is shown in FIG. 4 (d), (i) is NMR hydrogen spectrum, (ii) is NMR carbon spectrum, and (iii) is high-resolution mass spectrum.
The fourth step: 4- ((methyl (prop-2-yn-1-yl) amino) methyl) phenol (1 eq.), (E) -cyclooct-4-en-1-yl (2-bromoethyl) carbamate (1.2 eq.), potassium carbonate (2 eq.) were dissolved in acetonitrile solution and heated under reflux for 12h under nitrogen. After the reaction was complete, the solvent was spin dried. 1M dilute hydrochloric acid was added to adjust the pH to 7.0. Dichloromethane was added for extraction. Drying with anhydrous sodium sulfate, purifying by flash column chromatography, and spin-drying to obtain final product PA-TCO. The spectrum analysis is shown in FIG. 4 (e), (i) is NMR hydrogen spectrum, (ii) is NMR carbon spectrum, and (iii) is high resolution mass spectrum.
Example 3 simulation of the recognition of specific probes by molecular docking (the mechanism of recognition of specific probes for MAO-A/MAO-B is the same)
As shown in FIG. 5, 200. Mu.L of a monoamine oxidase reaction system including PBS buffer with pH =7.4, monoamine oxidase A/B (50. Mu.g/mL), CL-TCO/PA-TCO (20. Mu.M) was prepared in advance, and preincubated at 37 ℃ with shaking for 1h.
Example 4 purification of specifically bound protein-probe conjugates by separation column
Placing a separation column: the bottom seal of the column was removed (the lid was released) and placed in a 2.0mL collection tube and centrifuged at 1500 Xg for 1min to remove the stock solution. The column is marked on the upwardly inclined side of the compacted resin and the mark is kept outward during all subsequent centrifugation steps.
Sample loading: a0.5 mL fresh centrifuge tube was placed on the column, the lid removed, and the 200. Mu.L reaction was slowly placed in the center of the compacted resin bed and centrifuged at 1500 Xg for 2min to collect the specifically bound protein-probe conjugate.
Example 5 bioorthogonal reaction fluorescence assay
(1) A dye solution of 1 μ M1,2,4, 5-tetrazine structure (the 1,2,4, 5-tetrazine structure is as follows) was prepared with PBS buffer solution of pH =7.4Tz-TER), 100 μ of 10 μ M specifically bound MAO-A-CL-TCO conjugate solution was mixed with 100 μ of 1 μ M1,2,4, 5-tetrazine structured dye solution, and shaken at 37 ℃ for 20min. After 20min of reaction, fluorescence scan detection (Ex =505 nm) was performed, and the results are shown in fig. 6.
(2) mu.M dye solution of 1,2,4, 5-tetrazine structure was prepared with PBS buffer pH =7.4, 100. Mu.L of 10. Mu.M specifically bound MAO-B-PA-TCO conjugate solution was mixed with 100. Mu.L of 1. Mu.M dye solution of 1,2,4, 5-tetrazine structure, and shaken at 37 ℃ for 20min. After 20min of reaction, fluorescence scan detection (Ex =505 nm) was performed, and the results are shown in fig. 7.
If the probe does not specifically bind to the protein, the protein sample separated from the separation column will be a protein sample without the probe, and will not undergo bioorthogonal reaction with the dye of 1,2,4, 5-tetrazine structure, and will not produce fluorescence enhancement effect. If the probe binds specifically to the protein, a sample of the protein-probe conjugate that will be specifically bound that is separated from the separation column will undergo a bio-orthogonal reaction with the dye of the 1,2,4, 5-tetrazine structure, resulting in an increase in fluorescence. As can be seen from FIGS. 6 and 7, the fluorescence intensity after the reaction was increased, confirming that all the proteins in the sample separated from the rotary spin column had been specifically bound by the probe. The active small molecule probe provided by the invention can specifically detect monoamine oxidase.
In conclusion, the specific probe (E) -N- (3- (2-chloro-4- ((cyclooctane-4-ene-1-oxy) methyl) phenoxy) propyl) -N-methylpropane-2-alkyne-1-amine of MAO-A is designed, and is represented by C-TCO (the C-TCO molecular structure is shown in figure 1), the characteristic structure of the probe, namely propargylamine substituted chlorophenol can be used as A targeting part, and the MAO-A is specifically, quantitatively and covalently bound; a specific probe (E) -cyclooctane-4-ene-1-yl (2- (4- ((methyl (prop-2-yne-1-yl) amino) methyl) phenoxy) ethyl) carbamate of MAO-B is also designed, PA-TCO is used for representing below (the molecular structure of the PA-TCO is shown in figure 2), the characteristic structure of the probe, namely propargylamine substituted phenol can be used as a targeting moiety, and the mechanism of the specific probe for identifying the protein by covalent binding with MAO-B is specifically quantified and shown in figure 5. Meanwhile, the structures of the two probe molecules also comprise a trans-cyclooctene structure, so that the trans-cyclooctene structure can perform bio-orthogonal reaction with the dye molecules with 1,2,4, 5-tetrazine structures, the fluorescence of the product after the reaction is enhanced, and the activity of monoamine oxidase A/B in different biological systems can be measured through fluorescence change.
In view of the fast reaction rate and high fluorescence characteristic of the 1,2,4, 5-tetrazine structure in the chemical reaction, after the specific quantitative covalent binding of MAO-A/MAO-B and the corresponding probe, the dye molecule with the 1,2,4, 5-tetrazine structure and the trans-cyclooctene structure of the specific probe C-TCO/PA-TCO modified on MAO-A/MAO-B can generate the bio-orthogonal chemical reaction, and the fluorescence of the product is enhanced. The monoamine oxidase A/B activity in different biological systems can be determined by fluorescence change.
Claims (3)
1. The small molecular probe for specifically detecting the activity of monoamine oxidase is characterized in that the structural formula of the in vitro specific probe is shown as followsWherein R is 1 Is->When the in vitro specific probe is used, the structural formula of the in vitro specific probe is shown asWhen the probe is used, the probe is marked as C-TCO, and the in vitro specific probe is specifically combined with MAO-A; or R 1 Is composed ofIn which the in vitro specific probe has the formula->The in vitro specific probe binds specifically to MAO-B, denoted PA-TCO.
2. The method for preparing the small molecule probe for specifically detecting monoamine oxidase according to claim 1, wherein R1 isIn which the in vitro specific probe has the formula->The specific preparation method is as follows: the first step is as follows: dissolving 1eq of 2-chloro-4- ((methyl (prop-2-yn-1-yl) amino) methyl) phenol and 1.5eq of tert-butyldimethylchlorosilane in dichloromethane, adding dropwise triethanolamine under ice bath and nitrogen protection, reacting for 4-10h, adding water after the reaction is finished, extracting with dichloromethane, washing an organic phase with 1M dilute hydrochloric acid, adding anhydrous sodium sulfate, drying, purifying by flash column chromatography, and spin-drying to obtain tert-butyl (2-chloro-4-methylphenoxy) dimethylsilane; the second step: dissolving tert-butyl (2-chloro-4-methylphenoxy) dimethylsilane 1eq in carbon tetrachloride, adding N-bromosuccinimide 1eq under the ice bath condition, heating and refluxing for 3h, adding water for extraction, and drying anhydrous sodium sulfate to obtain (4- (bromomethyl) -2-chlorophenoxy) (tert-butyl) dimethylsilane; the third step: dissolving trans-cyclooctenol 1.5eq in N, N-dimethylformamide, slowly adding sodium hydride 2eq under the ice bath condition, stirring at room temperature for 30min, adding 4-hydroxy trans-cyclooctene 1eq, and reacting for 5-10h; after the reaction is finished, adding water to quench the reaction, extracting the reaction product by dichloromethane, drying the reaction product by anhydrous sodium sulfate, purifying the reaction product by flash column chromatography, and spin-drying the purified product to obtain (E) -tert-butyl (2-chloro-4- ((cycloocta-4-ene-1-oxyl) methyl) phenoxy) dimethylSilane; the fourth step: dissolving 1eq of (E) -tert-butyl (2-chloro-4- ((cyclooct-4-ene-1-oxyl) methyl) phenoxy) dimethyl silane in tetrahydrofuran, dropwise adding 1.2eq of tetrabutylammonium fluoride under the ice bath condition, stirring for 2-10h at room temperature, adding water after the reaction is finished, and quenching, and extracting by using dichloromethane; drying over anhydrous sodium sulfate, purifying by flash column chromatography, and spin-drying to obtain (E) -2-chloro-4- ((cyclooct-4-en-1-propoxy) methyl) phenol; the fifth step: dissolving 1eq of (E) -2-chloro-4- ((cyclooct-4-ene-1-propoxy) methyl) phenol and 2eq of 1, 3-dibromopropane in acetonitrile, adding 1eq of potassium carbonate, refluxing for 3h under the protection of nitrogen, cooling to room temperature, adding 3eq of N-methylpropane-2-amine and 3eq of potassium carbonate, and stirring for 22-48h at the temperature of 3eq.40 ℃; spin-drying the solvent, extracting with water and ethyl acetate; drying with anhydrous sodium sulfate; purifying by flash column chromatography, and spin-drying to obtain final compound CL-TCO; when R1 is->When the in vitro specific probe has the structural formula of->The specific preparation method is marked as PA-TCO and comprises the following steps: under the ice bath condition, dissolving 4-hydroxy trans-cyclooctene and pyridine at 1.2eq in dichloromethane, slowly dropwise adding 4-nitrophenylcarbonyl chloride at 1.2eq, stirring at room temperature for 10-20h, adding water and dichloromethane for extraction after the reaction is completed, washing an organic phase with 1M sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, purifying by flash column chromatography, and spin-drying to obtain (E) -cyclooct-4-en-1-yl (4-nitrophenyl) carbonate; the second step is that: dissolving 2-bromoethyl-1-amine 6eq in dichloromethane, slowly dropwise adding (E) -cyclooct-4-en-1-yl (4-nitrophenyl) carbonate 1eq under the protection of nitrogen, stirring at room temperature for 14-22h, and adding for extraction after the reaction is completed; washing the organic phase with aqueous sodium bicarbonate solution, drying over anhydrous sodium sulfate, purifying by flash column chromatography, and spin-drying to obtain (E) -cycloocta-4-en-1-yl (2-bromoethyl) carbamate; the third step: dissolving 4-hydroxybenzaldehyde 1eq in tetrahydrofuran, adding 4-hydroxybenzaldehyde 1.2eq under nitrogen protection, stirring the reaction mixture at room temperature for 30min, and adding sodium acetate 1.4eqReaction for 4-10h, quenching the reaction mixture with saturated sodium bicarbonate, extracting with ethyl acetate at 4 × 20mL, combining the organic layers, washing with saturated brine, drying over anhydrous sodium sulfate, purifying by flash column chromatography, and spin-drying to give 4- ((methyl (prop-2-yn-1-yl) amino) methyl) phenol; the fourth step: dissolving 1eq of 4- ((methyl (prop-2-yne-1-yl) amino) methyl) phenol, 1.2eq of (E) -cyclooct-4-ene-1-yl (2-bromoethyl) carbamate and 2eq of potassium carbonate in acetonitrile solution, heating and refluxing for 10-20h under the protection of nitrogen, after the reaction is completed, drying the solvent in a rotary manner, adding 1M diluted hydrochloric acid to adjust the pH to 7.0, adding dichloromethane for extraction, drying anhydrous sodium sulfate, purifying by flash column chromatography, and drying in a rotary manner to obtain the final product PA-TCO.
3. The use of the active small molecule probe according to claim 1 or 2 for detecting monoamine oxidase a/B, wherein the trans-cyclooctene structure of the specific probe produces strong fluorescence by bioorthogonal reaction with the dye having 1,2,4, 5-tetrazine structure, and the activity of monoamine oxidase a/B in various biological systems is measured by fluorescence change, and the specifically bound protein-probe solution is reacted with the dye solution having 1,2,4, 5-tetrazine structure in equal volumes, wherein the concentration of the protein solution modified by the specific probe is 5-50 times that of the dye solution having 1,2,4, 5-tetrazine structure, the reaction time is 5-30min, the reaction temperature is 20-37 ℃, and the fluorescence value of the reaction per unit time is measured as an evaluation index of monoamine oxidase a/B activity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210161073.3A CN114539078B (en) | 2022-02-22 | 2022-02-22 | Active small molecular probe for specifically sorting monoamine oxidase, preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210161073.3A CN114539078B (en) | 2022-02-22 | 2022-02-22 | Active small molecular probe for specifically sorting monoamine oxidase, preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114539078A CN114539078A (en) | 2022-05-27 |
CN114539078B true CN114539078B (en) | 2023-04-07 |
Family
ID=81676917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210161073.3A Active CN114539078B (en) | 2022-02-22 | 2022-02-22 | Active small molecular probe for specifically sorting monoamine oxidase, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114539078B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116425673A (en) * | 2023-04-12 | 2023-07-14 | 浙江工业大学 | N-propyne-pyridone derivative and preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080194522A1 (en) * | 2004-08-25 | 2008-08-14 | Gong Chen | Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) |
CN101703501B (en) * | 2009-09-29 | 2011-07-27 | 浙江工业大学 | Propargyl imine compounds and use thereof in preparation of MAO inhibitor |
CN101982170B (en) * | 2010-10-12 | 2012-02-29 | 浙江工业大学 | Amide compound and application thereof in preparing monoamine oxidase inhibitor |
KR101395457B1 (en) * | 2012-05-17 | 2014-05-15 | 포항공과대학교 산학협력단 | Novel two photon probes, method for preparing the same, and method for detecting substrates. |
-
2022
- 2022-02-22 CN CN202210161073.3A patent/CN114539078B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN114539078A (en) | 2022-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5616298A (en) | 5(6)-methyl substituted fluorescein derivatives | |
US9879300B2 (en) | Method and array for identifying histone-code-related analytes | |
JPS6324155A (en) | Cleavable mark used for coupling measuring method | |
CN114539078B (en) | Active small molecular probe for specifically sorting monoamine oxidase, preparation method and application thereof | |
CN107746367B (en) | β -caryophyllene derivative and preparation method and application thereof | |
CN107365342B (en) | Aldosterone derivative, immunogene and synthetic method, specific antibody and detection reagent and preparation method, kit | |
EP2048239B1 (en) | Glyceroglycolipid antigen of mycoplasma pneumoniae | |
US5367058A (en) | Modified antibodies with increased affinity | |
CN115850338A (en) | Compound containing diazirine nucleosides as well as preparation method and application thereof | |
KR101159011B1 (en) | hapten compound and antibody | |
CN102295698B (en) | Cyclosporine A immunogen, cyclosporine A specific antibody, detection reagent, and detection kit | |
CN108896523B (en) | Fluorescence enhancement type hypochlorite detection method and application | |
CN108949159B (en) | Fluorescent probe for detecting palladium ions and synthetic method and application thereof | |
CN114105874B (en) | Acrolein fluorescent probe and preparation method and application thereof | |
CN113324960B (en) | Antibody fluorescent probe, preparation method thereof and application thereof in visual cell detection | |
CN114544571B (en) | Method for constructing bioorthogonal reaction base paper device and application of bioorthogonal reaction base paper device in monoamine oxidase detection | |
JPH08511516A (en) | 3-Phenyl-1-adamantaneacetic acid hapten, tracer, immunogen and antibody | |
JP2002518413A (en) | New compounds | |
JP3431825B2 (en) | Anti-PAH monoclonal antibody and cell line producing the same | |
CN104844581B (en) | A kind of carbon carbon oxygen oxygen quaternary cycle compound and its application in Mass Spectrometer Method | |
CN118169263A (en) | Cell surface proteome in-situ analysis method based on interaction of host and guest and without calibration | |
CN118033113A (en) | Glycocholic acid latex enhanced immunonephelometry detection reagent and preparation method thereof | |
CN108299414B (en) | Two-photon fluorescent probe for selectively detecting iron (III) complex of biological mercaptan | |
JPH10104230A (en) | Method of detecting nucleic acid or the like, and labeled substance and detected substance | |
CN117447337A (en) | Tapentadol artificial hapten and artificial antigen as well as preparation methods and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |